82 related articles for article (PubMed ID: 15738602)
1. [Relationship between the expression of insulin-like growth factor I receptors and apoptosis after preliminary chemotherapy, in child and adolescent osteosarcoma].
Rytwiński K; Wnuk A; Woźniak W; Rychłowska M
Med Wieku Rozwoj; 2004; 8(2 Pt 1):267-73. PubMed ID: 15738602
[TBL] [Abstract][Full Text] [Related]
2. [Cytometric analysis of the relation between aneuploidy and expression of receptors for insulin growth factor I in child and adolescent osteosarcoma, after preliminary chemotherapy].
Rytwiński K; Wnuk A; Woźniak W; Rychłowska M
Med Wieku Rozwoj; 2004; 8(2 Pt 1):275-81. PubMed ID: 15738603
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of the correlation between proliferation defined by S-phase cell cycle and apoptosis after preoperative chemotherapy in osteosarcomas of children and adolescents].
Rytwiński K; Wnuk A; Woźniak W; Rychłowska M; Bieńkowska M
Med Wieku Rozwoj; 2004; 8(4 Pt 2):1029-36. PubMed ID: 15951597
[TBL] [Abstract][Full Text] [Related]
4. [Cytometric assessment of apoptosis and aneuploidy in relation to survival time in osteosarcomas of children and adolescents].
Rytwiński K; Woźniak W; Rychłowska M; Wnuk A
Med Wieku Rozwoj; 2004; 8(4 Pt 2):1021-8. PubMed ID: 15951596
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of DNA histograms and histopathologic assessment of necrosis after preoperative chemotherapy of osteosarcoma in children and youth].
Rytwiński K; Wnuk A; Klepacka T; Bilska K
Med Wieku Rozwoj; 2000; 4(2 Suppl 2):36-43. PubMed ID: 11178327
[TBL] [Abstract][Full Text] [Related]
6. Multiple drug resistance in osteosarcoma.
Rosier RN; Teot LA; Hicks DG; Schwartz C; O'Keefe RJ; Puzas JE
Iowa Orthop J; 1995; 15():66-73. PubMed ID: 7634047
[No Abstract] [Full Text] [Related]
7. Growth inhibition of insulin-like growth factor I receptor monoclonal antibody to human colorectal cancer cells.
Zhang Y; Zhang Y
Cancer Invest; 2008; 26(3):230-6. PubMed ID: 18317963
[TBL] [Abstract][Full Text] [Related]
8. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
Avnet S; Sciacca L; Salerno M; Gancitano G; Cassarino MF; Longhi A; Zakikhani M; Carboni JM; Gottardis M; Giunti A; Pollak M; Vigneri R; Baldini N
Cancer Res; 2009 Mar; 69(6):2443-52. PubMed ID: 19258511
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
[TBL] [Abstract][Full Text] [Related]
10. Chimaphilin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines through insulin-like growth factor-I receptor (IGF-IR) signaling.
Daqian W; Chuandong W; Xinhua Q; Songtao A; Kerong D
Chem Biol Interact; 2015 Jul; 237():25-30. PubMed ID: 25980584
[TBL] [Abstract][Full Text] [Related]
11. Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth.
Kappel CC; Velez-Yanguas MC; Hirschfeld S; Helman LJ
Cancer Res; 1994 May; 54(10):2803-7. PubMed ID: 8168113
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line.
Mackie PS; Fisher JL; Zhou H; Choong PF
Br J Cancer; 2001 Apr; 84(7):951-8. PubMed ID: 11286476
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of octreotide pamoate long-acting release and carboplatin versus carboplatin alone in dogs with naturally occurring osteosarcoma: evaluation of insulin-like growth factor suppression and chemotherapy.
Khanna C; Prehn J; Hayden D; Cassaday RD; Caylor J; Jacob S; Bose SM; Hong SH; Hewitt SM; Helman LJ
Clin Cancer Res; 2002 Jul; 8(7):2406-12. PubMed ID: 12114446
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor I (IGF-I) stimulates proliferation but also increases caspase-3 activity, Annexin-V binding, and DNA-fragmentation in human MG63 osteosarcoma cells: co-activation of pro- and anti-apoptotic pathways by IGF-I.
Raile K; Hille R; Laue S; Schulz A; Pfeifer G; Horn F; Kiess W
Horm Metab Res; 2003; 35(11-12):786-93. PubMed ID: 14710359
[TBL] [Abstract][Full Text] [Related]
15. Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases.
Bacci G; Ferrari S; Ruggieri P; Biagini R; Fabbri N; Campanacci L; Bacchini P; Longhi A; Forni C; Bertoni F
Acta Orthop Scand; 2001 Apr; 72(2):167-72. PubMed ID: 11372948
[TBL] [Abstract][Full Text] [Related]
16. Tumor volume increase during preoperative chemotherapy as a novel predictor of local recurrence in extremity osteosarcoma.
Song WS; Jeon DG; Kong CB; Cho WH; Koh JS; Lee JA; Yoo JY; Jung ST; Shin DS; Lee SY
Ann Surg Oncol; 2011 Jun; 18(6):1710-6. PubMed ID: 21222166
[TBL] [Abstract][Full Text] [Related]
17. [Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: results about 56 cases].
Boussen H; Mezzi F; Gamoudi A; Daldoul O; Ben Hamida H; Mezlini A; Khalfallah S; Karray S; Ben Romdhane K; Ben Ghachem M; Ben Abdallah M; Douik M; Saadi A; Ben Ayed F; Ben Hassine H
Bull Cancer; 2000 Feb; 87(2):183-8. PubMed ID: 10705289
[TBL] [Abstract][Full Text] [Related]
18. [Comparative histopathologic analysis of osteogenic sarcomas before and after initial chemotherapy].
Liebhart M
Patol Pol; 1989; 40(2):149-58. PubMed ID: 2637977
[TBL] [Abstract][Full Text] [Related]
19. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
[TBL] [Abstract][Full Text] [Related]
20. Cytostatic effects in osteosarcomas as detected by flow cytometric DNA analysis after preoperative chemotherapy according to the COSS 80/82 protocol.
Bösing T; Roessner A; Hiddemann W; Mellin W; Grundmann E
J Cancer Res Clin Oncol; 1987; 113(4):369-75. PubMed ID: 3474234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
